发明名称 Serine racemase inhibitor
摘要 A novel serine racemase inhibitor exhibits sufficient activity and specificity. The serine racemase inhibitor includes one or more compounds selected from compounds respectively represented by the following general formulas [MM_1], [DR_1], [DR′_1], [LW_1], and [ED_1] as an active ingredient.;
申请公布号 US9216954(B2) 申请公布日期 2015.12.22
申请号 US201314375006 申请日期 2013.01.24
申请人 NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA 发明人 Mori Hisashi;Toyooka Naoki;Mizuguchi Mineyuki;Obita Takayuki;Hirono Syuichi;Goda Hiroaki
分类号 C07C337/06;C07D333/24;C07D333/38;C07C311/13;C07C311/19;C07C311/29;C07C327/42;C07C335/08;C07C335/16;C07C335/18;C07C237/22;C07C311/21;C07C311/58 主分类号 C07C337/06
代理机构 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. 代理人 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Conlin David G.;Lee Joohee
主权项 1. An N-[(acyl)hydrazinocarbothioyl]acetamide derivative represented by a general formula [LW—1d], a salt thereof, a hydrate thereof, or a solvate thereof,wherein R13w is a halogen atom, R12w, R14w, R15w, and R16w are independently atoms selected from a hydrogen atom and a halogen atom, and R2bw is a substituted or unsubstituted phenyl group, or a substituted or unsubstituted thienyl group.
地址 Toyama JP